Table 1 Clinicopathological data regarding the patients from whom the sample both tumour and normal was collected
From: Fibronectin protein expression in renal cell carcinoma in correlation with clinical stage of tumour
Clinicopathological variables | ||
|---|---|---|
Number of patients (n = 21) | Percentage of patientspercentage of patientspercentage of patients | |
Age (n = 21) | ||
< 50 | 6 | 28.57 |
50–60 | 8 | 38.1 |
60–70 | 4 | 19.05 |
> 70 | 3 | 14.28 |
Sex (n = 21) | ||
Male | 14 | 66.67 |
Female | 7 | 33.33 |
Surgery (n = 21) | ||
Partial nephrectomy | 10 | 47.61 |
Radical nephrectomy | 11 | 52.39 |
Histology type by H & E staining (n = 21) | ||
Clear cell carcinoma | 15 | 71.43 |
Papillary carcinoma | 3 | 14.29 |
Chromophobe carcinoma | 2 | 9.52 |
Others / Multilocular cystic renal cell neoplasm | 1 | 4.76 |
Furhmann’s grade by H & E staining (n = 19) | ||
1 | 1 | 5.26 |
2 | 12 | 63.16 |
3 | 6 | 31.58 |
T – Primary tumour (n = 21) | ||
T1a | 5 | 23.81 |
T1b | 9 | 42.86 |
T2b | 2 | 9.52 |
T3a | 5 | 23.81 |
Lymph node metastasis (n = 21) | ||
Absent | 21 | 100 |
Distant metastasis (n = 21) | ||
Absent | 20 | 95.24 |
Present | 1 | 4.76 |
Stage (n = 21) | ||
I | 14 | 66.67 |
II | 2 | 9.52 |
III | 4 | 19.05 |
IV | 1 | 4.76 |
Tumour stroma percentage / TSP (n = 21) | ||
< 10% | 20 | 95.24 |
> 50% | 1 | 4.76 |